ResMed, Inc. (RMD) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $205.74 -1.3%
Revenue Growth %: +13.1%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: +13.1%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q2 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $376.5 million versus the consensus estimate of $363.76 million.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- JPMorgan cuts 2026 box office forecast on slow third quarter
- Needham Reiterates Hold Rating on ResMed (RMD)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
